Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-10
1999-02-09
Berch, Mark L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514262, 544276, 544277, C07D47318, C07D47332, A61K 3152
Patent
active
058694935
ABSTRACT:
Compounds of the Formula I ##STR1## where one of R.sub.1 and R.sub.2 is --C(O)CH(CH(CH.sub.3).sub.2)NH.sub.2 or --C(O)CH(CH(CH.sub.3)CH.sub.2 CH.sub.3)NH.sub.2;
REFERENCES:
patent: 5216142 (1993-06-01), Horrobin et al.
patent: 5543414 (1996-08-01), Nestor et al.
"Drug Evaluations Manual", 1993, (A.M.A.) p. 1723.
de Miranda, Antiviral Chem & Chemotherapy, 3(1), 1-8, 1992.
de Miranda, "Acyclovir Symposium" in Am. J. Medicine, vol. 73, p. 31, Jul. 28, 1992.
Benjamin et al., Pharmaceutical Research, 4, No. 2, 120-125 (1987).
Harnden et al., J. Med. Chem. 32, 1738-1743 (1989).
Lake-Bakaar et al., Antimicrobial Agents and Chemotherapy, 33, No. 1, 110-112 (1989).
Hodge et al., Antimicrobial Agents and Chemotherapy, 33, No. 10., 1765-1773 (1989).
Terao et al., Chem. Pharm. Bull. 39(3), 823-825 (1991).
Ohsawa et al., Chem. Pharm. Bull. 41(11) 1906-1909 (1993).
Lowe, Antimicrobial Agents and Chemotherapy, 39, No. 8, 1802-1808 (1995).
Kim et al., Bioorganic & Medicinal Chemistry Letters, 6, No. 15, 1849-1854 (1996).
Engelhardt Per
Hogberg Marita
Johansson Nils-Gunnar
Lindborg Bjorn
Zhou Xiao-Xiong
Berch Mark L.
Medivir AB
LandOfFree
Acyclic nucleoside derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acyclic nucleoside derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acyclic nucleoside derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1948629